Skip to content 
MoCRA For Private Label Skincare Brands
What do brands need to prepare before launching skincare products in the U.S.?
MoCRA is a major U.S. cosmetics regulation update. For private label skincare brands, it mainly affects how you prepare for U.S. launch, including facility registration, product listing, safety records, labeling, and complaint handling.
Most cosmetics still do not need FDA premarket approval, but brands do need a clearer compliance path before final artwork and bulk production.
What MoCRA Changes
Facility Registration · Product Listing · Safety Records · Label And Complaint Readiness
What Is MoCRA And Why Does It Matter For Private Label Skincare Brands?
MoCRA is a major U.S. cosmetics regulation update. For private label skincare brands, it matters because U.S. launch now requires more attention to registration, product listing, safety records, labeling, and complaint handling.
A private label launch is no longer only about formula, packaging, and price. Brands also need a clearer compliance path before bulk production and final artwork approval.
Registration
Facility-related requirements need early confirmation
Listing
Product information should be prepared before launch
Safety
Supporting records should not wait until the last step
Labeling
Claims and pack text need compliance review
Complaints
Post-market handling should be defined in advance
This is a practical summary based on FDA’s MoCRA framework.
Does MoCRA Mean Your Skincare Products Need FDA Approval Before Sale?
No. Most skincare products do not need FDA premarket approval before sale. Under U.S. law, cosmetic products and ingredients generally do not require FDA approval, except for color additives.
MoCRA does not turn cosmetics into drugs. What it changes is how carefully brands should prepare for launch and what records and responsibilities should already be clear before the product goes to market.
What Brands Should Understand Clearly
- No general pre-approval — most cosmetics can go to market without FDA pre-approval
- Color additives are different — approval or certification may apply depending on use
- FDA-regulated does not mean FDA-approved — compliance still matters before and after launch
- Brands still carry responsibility — products must be safe, properly labeled, and not misbranded or adulterated
FDA Approval Vs FDA Regulation
- Most cosmetics: FDA-regulated, not pre-approved
- Color additives: approval or certification may apply
At Zerun Cosmetic, we help private label skincare brands prepare the formula, labeling, and supporting documents needed for a smoother U.S. launch, while keeping the product positioned within the correct cosmetic compliance path.
Who Is The Responsible Person In A Private Label Project?
Under MoCRA, the responsible person is the manufacturer, packer, or distributor whose name appears on the cosmetic product label. In many private label projects, that is often the brand named on pack, not automatically the factory.
This matters because the responsible person is tied to key obligations such as product listing and serious adverse event reporting. The company named on the label should not assume the factory is handling everything unless roles are clearly defined in advance.
Brand
If the brand name appears on label, it may be the responsible person.
Distributor
If the distributor name appears on label, it may take that role.
Manufacturer
Making the product does not automatically make the factory the responsible person.
These are practical role-split questions based on FDA’s responsible person framework.
What Must Be Registered Or Listed Under MoCRA?
Under MoCRA, facility registration and cosmetic product listing are two different requirements. The manufacturing facility may need to be registered, and the marketed cosmetic product may need to be listed. They are not the same task.
For most brands, the practical question is simple: which site is linked to the product, and who will prepare the information needed for listing? FDA states that facilities subject to the rule must register and renew biennially, while responsible persons must submit product listings and keep them updated annually.
| Item | Facility Registration | Product Listing |
|---|---|---|
| Covers | Manufacturing / processing site | Marketed cosmetic product |
| Usually tied to | Factory / production facility | Responsible person / listed product |
| Update rhythm | Biennial | Annual |
What Brands Should Keep Clear
- Facility registration is about the production site.
- Product listing is about the product sold in the U.S.
- The factory and the responsible person may not be the same party.
- Both should be clarified before launch planning moves too far.
Quick Reminder
Facility registration and product listing are connected, but they are not the same step. Brands should confirm both before final artwork approval and bulk production. This final sentence is an implementation recommendation based on FDA’s registration and listing framework.
What Safety Records Should A Brand Prepare Before Launch?
A private label skincare brand should prepare a clear safety substantiation file before U.S. launch. Under MoCRA, the responsible person must ensure and maintain records supporting adequate safety substantiation for the cosmetic product. FDA also states there is no single mandatory test package that fits every cosmetic product.
The goal is not to collect random reports. The goal is to organize enough scientifically sound information to support that the product is safe under labeled or customary conditions of use.
Formula File
Formula, INCI, and core raw material information.
Ingredient Support
Key ingredient background and supporting safety information.
Safety Substantiation
Records showing why the product is considered safe for intended use.
Testing Plan
Stability, microbiological, compatibility, or other product-specific checks.
File Updates
Define who keeps records current after formula or pack changes.
How Does MoCRA Affect Labeling And Claims?
MoCRA does not make cosmetic labeling a pre-approval process, but it makes labeling and claims even more important in launch preparation. Cosmetic labels are not pre-approved by FDA, yet they still need to meet legal requirements and stay within cosmetic boundaries.
For private label skincare brands, label work is not only a design task. It is also a compliance task. The brand needs to check required label elements, keep claims within cosmetic positioning if that is the intended route, and make sure label, website, and marketplace wording all point to the same intended use.
Quick Clarification
Cosmetic labeling = regulated, not pre-approved
Cosmetic claims = no FDA-approved claim list
Drug-like claims = can change the product route
Label Basics
Check that required cosmetic label elements are complete.
Claim Boundary
Keep cosmetic claims within cosmetic positioning.
Channel Consistency
Label, website, ads, and marketplace copy should align.
Ingredient Naming
Use the correct cosmetic naming approach.
Warnings
Add any format-specific warning or special statement if needed.
What Should A Private Label Brand Ask A Manufacturer About MoCRA Readiness?
Do not assume a factory is MoCRA-ready just because it can make the product. Brands should ask clear questions about registration support, listing data, safety records, label review, and complaint handling before artwork approval and bulk production.
In private label projects, production and compliance support are not always handled by the same party. The right questions help brands confirm whether the factory can support a cleaner U.S. launch process, not just product manufacturing.
Registration
Can the facility support registration-related requirements?
Listing Data
What product and site information can the factory provide?
Safety Records
What substantiation or testing support is available?
.
Label Review
Will final label text be checked before bulk production?
Complaint Handling
How will records and label files be shared if needed?
Change Control
A factory that can produce your skincare product is not always a factory that can support a cleaner MoCRA preparation path.
A factory that can produce your skincare product is not always a factory that can support a cleaner MoCRA preparation path.
A Practical MoCRA Preparation Checklist Before U.S. Launch
Before launching a private label skincare product in the U.S., brands should confirm a basic MoCRA preparation checklist covering role definition, facility route, listing data, safety records, labeling, and complaint handling. The goal is to avoid preventable gaps before artwork approval and bulk production.
MoCRA preparation works best when brands treat it like a launch-readiness checklist, not a last-minute legal task. A simple checklist helps brands see what is already ready and what still needs follow-up before launch.
Before U.S. Launch, Confirm These
Role split confirmed — responsible person and support roles are clear
Facility route confirmed — the manufacturing site tied to the product is identified
Listing information prepared — product identity, category, ingredients, and site details are organized
Safety file organized — formula and safety support are ready
Label text reviewed — required label elements and claim boundaries are checked
Complaint path defined — intake, review, escalation, and documentation are clear
Change control aligned — formula, packaging, fragrance, or artwork changes can be tracked
This checklist is a practical summary based on FDA’s MoCRA structure.
A clear checklist early usually means a smoother launch later.
What Happens If There Is A Serious Adverse Event?
If a serious adverse event is reported in the U.S., the responsible person must report it to FDA within 15 business days and include a copy of the product label. If new medical or other relevant information is received within 1 year of the initial report, that follow-up information must also be submitted within 15 business days.
For private label skincare brands, this means complaint handling cannot be treated as a customer-service issue only. Once a complaint may qualify as a serious adverse event, the brand needs a clear intake, review, and escalation path.
Intake
Who receives the complaint first?
Review
How is seriousness checked?
Label Access
Can the label file be retrieved quickly?
Follow-Up
How is new medical information tracked?
Role Split
Who documents and who submits if needed?
How Can A Manufacturer Help Brands Prepare For MoCRA More Smoothly?
A manufacturer can help a brand prepare for MoCRA more smoothly by supporting the project with clearer facility information, listing data, safety records, label review support, batch and change records, and complaint-response coordination. But the factory does not automatically replace the brand’s responsibilities, especially when the brand is the responsible person named on the label.
The best factory support is not “we handle everything.” It is a clearer workflow: the manufacturer helps organize technical and production-side information, while the brand confirms label name, claims, launch decisions, and responsible-person obligations. This role split follows FDA’s current MoCRA framework.
A Manufacturer Can Help With vs A Manufacturer Does Not Replace
| Area | Manufacturer Can Help With | Brand Still Needs To Confirm |
|---|---|---|
| Facility data | Site information for listing support | Final listing path |
| Safety file | Formula and support records | Launch file readiness |
| Label review | Basic pack and ingredient review | Final claims and positioning |
| Change control | Communicating updates early | Market document updates |
| Complaint handling | Retrieving records quickly | Responsible-person response path |
Good support means clearer coordination, not unclear responsibility.
Need A Clearer U.S. Launch Path?
If a private label skincare project is intended for the U.S. market, MoCRA preparation should be clarified before final artwork, bulk production, and marketplace launch. The earlier the role split, listing path, safety file, label review, and complaint process are defined, the smoother the project usually moves. This is a practical conclusion based on FDA’s MoCRA framework.
What To Align First
- Product route as a cosmetic
- Responsible person path
- Facility and listing information
- Safety file scope
- Label and claim review
- Complaint-response workflow
- Our team will answer your inquiries within 12 hours.
- Your information will be kept strictly confidential.
